novo nordisk semaglutide alzheimer trial An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of Alzheimer's disease in closely watched trials, Nordisk… Novo Nordisk Alzheimer's trial: Novo

Know that your appetite will likely be higher, which can result in your eating more at meals and snacks

For example, some fraudulent GLP-1s contain insulin, which has been used as an additive instead of the common active ingredients contained in GLP-1 products, which stimulate the pancreas to naturally produce insulin

Furthermore, it is to determine whether the risk may differ by GLP-1RA type, trial duration, control type, and indication

Meta-analyses further revealed that in individuals at high cardiovascular risk, semaglutide reduced AF episodes by 42% (125)

Discomfort is usually minimal

Not a Quick Fix : While it supports weight management, it should be combined with healthy eating and exercise for optimal results